Title
Cardiac amyloidosis secondary to waldenström macroglobulinemia
Other title
Amiloidosis cardiaca secundaria a macroglobulinemia de waldenström
Date Issued
01 January 2020
Access level
metadata only access
Resource Type
journal article
Author(s)
Lachira-Yparraguirre L.
Al-Kassab-córdova A.
Quispe-Silvestre E.
Publisher(s)
Editorial Ciencias Medicas
Abstract
Introduction: Waldenström's macroglobulinemia is a hematological neoplasm belonging to the group of monoclonal gammopathies, which includes systemic symptoms and those related to an increase in M paraprotein. Objective: To describe a case of cardiac amyloidosis associated with macroglobulinemia. Clinical case: Male patient who was admitted for asthenia, dysphonia, and who, during his evolution, developed progressive dyspnea, heart failure and pleural effusion. Additionally, echocardiography showed myocardial granular pattern, while pleural biopsy was positive for Congo red staining. Subsequently, he received treatment with bortezomib, dexamethasone and rituximab, with favorable evolution. Conclusions: In this disease, early diagnosis is an important advantage for survival. Therefore, its management is palliative of cardiac manifestations. The present case shows a diagnostic challenge, in which the less frequent etiologies of heart failure must be taken into account.
Start page
1
End page
11
Volume
36
Issue
3
Language
Spanish
OCDE Knowledge area
Sistema cardiaco, Sistema cardiovascular Genética, Herencia Otros temas de medicina clínica
Scopus EID
2-s2.0-85098080520
Source
Revista Cubana de Hematologia, Inmunologia y Hemoterapia
ISSN of the container
08640289
Sources of information: Directorio de Producción Científica Scopus